Enzo Biochem Inc (ENZ.N)
19 Jan 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|67||2009||President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Director|
|74||2009||Chairman of the Board, Chief Executive Officer, Secretary|
|51||2015||Executive Vice President - Finance|
|59||2016||Vice President - Sales and Marketing, Enzo Clinical Labs|
|54||2014||Chief Medical Director, Enzo Clinical Labs|
- BRIEF-Enzo Biochem Q1 Non-GAAP Loss Per Share $0.01
- BRIEF-Enzo Biochem announces NYS department of health's approval of a new women's health infectious disease panel
- CORRECTED-BRIEF-Enzo Biochem Q4 non-gaap net income of $0.00 per share (Sept 27)
- BRIEF-Enzo Biochem files for mixed shelf of up to $150 million
- BRIEF-Enzo Biochem says federal judge in a U.S. Court has entered an order in action entitled Enzo Life Sciences v. Abbott Laboratories